111 related articles for article (PubMed ID: 34021911)
1. SOX9 has distinct roles in the formation and progression of different non-small cell lung cancer histotypes.
Bao J; Närhi K; Teodòsio A; Hemmes A; Linnavirta NM; Mäyränpää MI; Salmenkivi K; Le Quesne J; Verschuren EW
J Pathol; 2021 Sep; 255(1):16-29. PubMed ID: 34021911
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.
Zhou CH; Ye LP; Ye SX; Li Y; Zhang XY; Xu XY; Gong LY
J Exp Clin Cancer Res; 2012 Mar; 31(1):18. PubMed ID: 22385677
[TBL] [Abstract][Full Text] [Related]
3. Expression and correlation of MALAT1 and SOX9 in non-small cell lung cancer.
Chen W; Zhao W; Chen S; Zhang L; Guo Z; Wang L; Wang J; Wan Z; Hong Y; Yu L
Clin Respir J; 2018 Jul; 12(7):2284-2291. PubMed ID: 29896925
[TBL] [Abstract][Full Text] [Related]
4. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
5. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
6. SOX9-mediated UGT8 expression promotes glycolysis and maintains the malignancy of non-small cell lung cancer.
Ji J; Xie M; Qian Q; Xu Y; Shi W; Chen Z; Ren D; Liu W; He X; Lv M; Ma J; Liu W; Li A; Liu B
Biochem Biophys Res Commun; 2022 Jan; 587():139-145. PubMed ID: 34872002
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HIF-2α-Dependent NEAT1 Promotes the Progression of Non-Small Cell Lung Cancer through miR-101-3p/SOX9/Wnt/β-Catenin Signal Pathway.
Kong X; Zhao Y; Li X; Tao Z; Hou M; Ma H
Cell Physiol Biochem; 2019; 52(3):368-381. PubMed ID: 30845377
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
Qi G; Li L
Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
[TBL] [Abstract][Full Text] [Related]
9. SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity.
Zhong H; Lu W; Tang Y; Wiel C; Wei Y; Cao J; Riedlinger G; Papagiannakopoulos T; Guo JY; Bergo MO; Kang Y; Ganesan S; Sabaawy HE; Pine SR
Oncogene; 2023 Jun; 42(27):2183-2194. PubMed ID: 37258742
[TBL] [Abstract][Full Text] [Related]
10. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
[TBL] [Abstract][Full Text] [Related]
11. Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells.
Chanvorachote P; Luanpitpong S
Am J Physiol Cell Physiol; 2016 May; 310(9):C728-39. PubMed ID: 26911281
[TBL] [Abstract][Full Text] [Related]
12. miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9.
Li Z; Li B; Niu L; Ge L
Oncol Rep; 2017 Jan; 37(1):297-304. PubMed ID: 28004116
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30e inhibits proliferation and invasion of non-small cell lung cancer via targeting SOX9.
Cui Y; Zhao L; Zhao S; Guo T; Li F; Li Z; Fang L; Wu T; Gu C
Hum Cell; 2019 Jul; 32(3):326-333. PubMed ID: 31079325
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma.
Calles A; Sholl LM; Rodig SJ; Pelton AK; Hornick JL; Butaney M; Lydon C; Dahlberg SE; Oxnard GR; Jackman DM; Jänne PA
Clin Cancer Res; 2015 Jun; 21(12):2851-60. PubMed ID: 25737507
[TBL] [Abstract][Full Text] [Related]
15. Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1.
Nagaraj AS; Lahtela J; Hemmes A; Pellinen T; Blom S; Devlin JR; Salmenkivi K; Kallioniemi O; Mäyränpää MI; Närhi K; Verschuren EW
Cell Rep; 2017 Jan; 18(3):673-684. PubMed ID: 28099846
[TBL] [Abstract][Full Text] [Related]
16. Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma.
Becker-Santos DD; Thu KL; English JC; Pikor LA; Martinez VD; Zhang M; Vucic EA; Luk MT; Carraro A; Korbelik J; Piga D; Lhomme NM; Tsay MJ; Yee J; MacAulay CE; Lam S; Lockwood WW; Robinson WP; Jurisica I; Lam WL
J Pathol; 2016 Oct; 240(2):161-72. PubMed ID: 27357447
[TBL] [Abstract][Full Text] [Related]
17. Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma.
Capaccione KM; Hong X; Morgan KM; Liu W; Bishop JM; Liu L; Markert E; Deen M; Minerowicz C; Bertino JR; Allen T; Pine SR
Oncotarget; 2014 Jun; 5(11):3636-50. PubMed ID: 25004243
[TBL] [Abstract][Full Text] [Related]
18. lncRNA DLEU2 modulates cell proliferation and invasion of non-small cell lung cancer by regulating miR-30c-5p/SOX9 axis.
Zhou Y; Shi H; Du Y; Zhao G; Wang X; Li Q; Liu J; Ye L; Shen Z; Guo Y; Huang Y
Aging (Albany NY); 2019 Sep; 11(18):7386-7401. PubMed ID: 31541993
[TBL] [Abstract][Full Text] [Related]
19. The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer.
Voronkova MA; Rojanasakul LW; Kiratipaiboon C; Rojanasakul Y
Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31658996
[TBL] [Abstract][Full Text] [Related]
20. WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
Donati V; Fontanini G; Dell'Omodarme M; Prati MC; Nuti S; Lucchi M; Mussi A; Fabbri M; Basolo F; Croce CM; Aqeilan RI
Clin Cancer Res; 2007 Feb; 13(3):884-91. PubMed ID: 17289881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
